Sales rise for blood-screening system kits, company reports

03/1/2012 | CBS MoneyWatch

Cerus reported it saw an increase in revenue in the fourth quarter due in part to higher sales of disposable kits used with its Intercept blood-screening system, which eliminates bacteria, viruses and parasites in donated platelets. The company said it is preparing to initiate two late-stage clinical trials involving its screening system for red blood cells.

View Full Article in:

CBS MoneyWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT